Defendant Name: Cardinal Health, Inc.

Defendant Type: Public Company
SIC Code: 8099
CUSIP: 14149Y10

Initial Case Details

Legal Case Name In the Matter of Cardinal Health, Inc.
First Document Date 28-Feb-2020
Initial Filing Format Administrative Action
File Number 3-19718
Allegation Type Foreign Corrupt Practices Act
AAER 4118

Violations Alleged

Exchange Act
Sec 13(b)(2)(A)
Sec 13(b)(2)(B)


First Resolution Date 28-Feb-2020
Headline Total Penalty and Disgorgement

See Related Documents

Related Documents:

34-88303 28-Feb-2020 Administrative Proceeding
Order Instituting Cease-and-Desist Proceedings Pursuant to Section 21C of the Securities Exchange Act of 1934, Making Findings, and Imposing a Cease-and-Desist Order
On February 28, 2020, the SEC instituted settled cease-and-desist proceedings against Cardinal Health, Inc. The SEC stated: "These proceedings arise out of Cardinal's violations of the internal accounting controls and recordkeeping provisions of the Foreign Corrupt Practices Act of 1977 (the "FCPA") through the operations of its former subsidiary in China."
2020-48 28-Feb-2020 Press Release--Administrative Proceeding
SEC Charges Cardinal Health With FCPA Violations
The SEC "announced that Ohio-based pharmaceutical company Cardinal Health, Inc. has agreed to pay more than $8 million to resolve charges that it violated the books and records and internal accounting controls provisions of the Foreign Corrupt Practices Act (FCPA)."